Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06567795 · ClinicalTrials.gov registry record
PRimary IndividualiZed Evaluation of Cardiovascular Events in Patients With Diabetes Mellitus Using hemoTAG
A clinical trial of Diabetes Mellitus, Type 2 and Cardiovascular Diseases, sponsored by Aventusoft.
- Recruiting
- Registry status
- 189
- Enrollment target
- 1
- Study location
NCT06567795 is a study of Diabetes Mellitus, Type 2 and Cardiovascular Diseases that is actively recruiting participants, run by Aventusoft. The registered enrollment target is 189 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06567795, a study of Diabetes Mellitus, Type 2 and Cardiovascular Diseases, is actively recruiting participants, sponsored by Aventusoft.
- RECRUITING
- Registry status
- 189 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the proportion of diabetic mellitus patients with CV events as measured by HEMOTAG.
Conditions Studied
Interventions
- DEVICE Hemotag
Study Locations (1)
Florida
- Metabolic Research Institute, Inc - West Palm Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 189 participants |
| Start Date | 2024-03-14 |
| Est. Completion | 2027-03-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06567795
The ClinicalTrials.gov registry entry for NCT06567795 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 189 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (96% lower). The listed sponsor is Aventusoft, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which Hemotag is the first listed.
NCT06567795 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06567795 about?
NCT06567795 is a clinical study titled "PRimary IndividualiZed Evaluation of Cardiovascular Events in Patients With Diabetes Mellitus Using hemoTAG". To evaluate the proportion of diabetic mellitus patients with CV events as measured by HEMOTAG.
What is the current status of trial NCT06567795?
This trial is currently recruiting. The enrollment target is 189 participants. The study started on 2024-03-14. Estimated completion is 2027-03-18.
What conditions does trial NCT06567795 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Cardiovascular Diseases, Coronary Artery Disease, Peripheral Artery Disease, Cerebrovascular Disease.
What interventions are being tested in trial NCT06567795?
The interventions under investigation include: Hemotag (DEVICE).
Who is sponsoring clinical trial NCT06567795?
This trial is sponsored by Aventusoft, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06567795 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Drug Interaction Potential of Pro-Inflammatory Conditions
RECRUITING
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)
RECRUITING · Phase 1
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.